Hoth Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.437; its P/E ratio is -0.49; Hoth Therapeutics is scheduled to report earnings on November 10, 2020, and the estimated EPS forecast is $-2.50. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	$ 1.55K	-	$ 65.77M	$ 0.00
Gross Profit	$ -30.00K	$ 1.55K	$ 30.00K	$ 65.74M	-
EBIT	$ -1.48M	$ -797.80K	$ 1.48M	$ -3.48M	$ -2.68M
EBITDA	$ -1.48M	$ -797.80K	$ 1.48M	$ -3.48M	$ -2.68M
Net Income Common Stockholders	$ -2.09M	$ -1.87M	$ 1.48M	$ -3.47M	$ -2.64M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 11.85M	$ 11.57M	$ 13.23M	$ 6.64M	$ 9.27M
Total Assets	$ 12.09M	$ 11.92M	$ 13.46M	$ 6.76M	$ 9.89M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -11.85M	$ -11.57M	$ -13.23M	$ -6.64M	$ -9.27M
Total Liabilities	$ 1.58M	$ 1.97M	$ 1.56M	$ 1.64M	$ 1.28M
Stockholders Equity	$ 10.51M	$ 9.95M	$ 11.87M	$ 5.12M	$ 8.61M
Cash Flow	-
Free Cash Flow	$ -1.64M	$ -1.45M	$ -2.29M	$ -2.55M	$ -2.38M
Operating Cash Flow	$ -1.64M	$ -1.45M	$ -2.29M	$ -2.55M	$ -2.39M
Investing Cash Flow	-	-	-	$ -7.50K	$ 9.95K
Financing Cash Flow	$ 2.41M	-	$ 8.91M	$ 50.99K	$ 0.00

Currency in USD

Hoth Therapeutics Earnings and Revenue History

Income Statement >

Hoth Therapeutics Debt to Assets

Balance Sheet >

Hoth Therapeutics Cash Flow

Cash Flow >

Hoth Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing